Through content transformation and multilingual data analysis, our combination of AI-enabled technology and human expertise helps our clients to grow by ensuring they are understood anywhere, in any language.
We work with 84 of the top 100 global brands, 19 of the top 20 pharmaceutical companies and 18 of the top 20 patent filers worldwide.
2023 Annual Report
RWS has made solid progress in delivering its strategy, particularly in respect of its growth initiatives, transformation programme, efficiency drive and the expansion of its portfolio, against the backdrop of a challenging market environment.
Our global scale and reach, diverse end markets and high levels of client retention and satisfaction allow us to navigate these impacts while maintaining dividends, returning excess capital to shareholders and continuing to invest in the business.